Hematopoietic Stem Cell TransplantationTransplantation, AutologousStem Cell TransplantationTransplantation, HomologousHost vs Graft ReactionTransplantation ConditioningPeripheral Blood Stem Cell TransplantationGraft vs Host DiseaseMultiple MyelomaMelphalanStem CellsTreatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsHematologic NeoplasmsCombined Modality TherapyRemission InductionBone Marrow TransplantationMyeloablative AgonistsRecurrenceSalvage TherapyDisease-Free SurvivalTissue DonorsTransplantation ChimeraBusulfanB-LymphocytesCyclophosphamideSurvival RateGraft SurvivalHodgkin DiseaseSurvival AnalysisHematopoietic Stem Cell MobilizationRetrospective StudiesCytarabineWhole-Body IrradiationEtoposideHematopoietic Stem CellsLymphoma, Non-HodgkinGraft vs Leukemia EffectLiver TransplantationVidarabineLeukemia, Myeloid, AcuteCarmustineHistocompatibility TestingGraft vs Tumor EffectVincristineCord Blood Stem Cell TransplantationPrognosisImmunosuppressive AgentsFollow-Up StudiesNeoplasm, ResidualThiotepaTime FactorsBone Marrow PurgingMesenchymal Stem Cell TransplantationAntigens, CD34Myelodysplastic SyndromesLeukemiaLymphocyte TransfusionAntibodies, Monoclonal, Murine-DerivedAntineoplastic AgentsLymphoma, Mantle-CellCell TransplantationHistocompatibilityLymphoma, FollicularSiblingsGranulocyte Colony-Stimulating FactorAmyloidosisKidney TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-LymphomaCytomegalovirus InfectionsDoxorubicinEmbryonic Stem CellsLymphomaDexamethasoneAntilymphocyte SerumBoronic AcidsLymphocyte DepletionAntineoplastic Agents, AlkylatingPyrazinesMinor Histocompatibility AntigensT-LymphocytesHepatic Veno-Occlusive DiseaseChimerismAdult Stem CellsAcute DiseaseThalidomideLeukapheresisVirus ActivationLeukemia, MyeloidAutograftsLymphoma, T-Cell, PeripheralCell DifferentiationHLA AntigensTransplantation ImmunologyAntibodies, MonoclonalIfosfamideHematologic DiseasesProspective StudiesPrednisone